Baxter AG is a MedTech company based in Opfikon (Zurich) recorded by Swissmedic as the authorisation holder for 30 human medicines. That places it 55 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | MedTech |
|---|---|
| City | Opfikon |
| Canton | Zurich |
| Authorisation holder | Yes |
| Medicines | 30 |
| Founded | Not available |
| Employees | 51-200 |
| Parent group | Baxter International |
| Activity | Not available |
| Website | baxter.ch |
Medicines authorised in Switzerland
Baxter AG is recorded by Swissmedic as the authorisation holder for 30 human medicines. The table shows 30 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
30 of 30 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| ARTISS 2 ml | 58618 | B | B02BC30 | 2009-07-15 |
| Bleomycin Baxter | 35856 | A | L01DC01 | 1970-09-10 |
| Brevibloc 100 mg | 49576 | B | C07AB09 | 1990-03-20 |
| Caelyx | 54273 | A | L01DB01 | 1997-12-24 |
| Cernevit | 47953 | B | B05XC | 1987-11-27 |
| ClinOleic 20 % | 55100 | B | B05BA02 | 2000-05-25 |
| Dexmedetomidine Baxter 200 μg/2 ml | 68249 | A | N05CM18 | 2022-10-26 |
| Endoxan | 25441 | A | L01AA01 | 1960-08-24 |
| Endoxan 200 mg | 25442 | A | L01AA01 | 1960-10-25 |
| Glucosalin 2:1 Baxter | 43131 | B | - | 1984-09-08 |
| Glucose 5 % Baxter | 41203 | B | B05BA03 | 1979-03-13 |
| Holoxan 500 mg | 41217 | A | L01AA06 | 1979-09-11 |
| Isofluran Baxter | 53250 | B | N01AB06 | 1996-01-23 |
| Natriumchlorid 0 | 41181 | B | B05BB01 | 1979-03-28 |
| Numeta Neo | 61336 | B | B05BA10 | 2011-10-28 |
| Numeta Ped G16% E | 61425 | B | B05BA10 | 2012-01-18 |
| Nutryelt | 66336 | B | B05XA31 | 2018-05-08 |
| Nutryelt Junior 10 ml | 67134 | B | B05XA31 | 2019-04-26 |
| OLIMEL 3 | 58182 | B | B05BA10 | 2009-03-24 |
| OLIMEL 4 | 59377 | B | B05BA10 | 2009-03-24 |
| PeriOLIMEL 2 | 59376 | B | B05BA10 | 2009-03-24 |
| Plasma-Lyte A | 56078 | B | B05BB01 | 2005-03-24 |
| Ringer-Lactat + Glucose 5% Baxter | 55933 | B | - | 2002-07-11 |
| Ringer-Lactat Baxter | 41207 | B | - | 1979-03-13 |
| Sevoflurane Baxter | 57671 | B | N01AB08 | 2006-11-30 |
| Suprane | 52611 | B | N01AB07 | 1995-01-09 |
| TISSEEL 2 ml | 52618 | B | B02BC10 | 1994-06-02 |
| Uromitexan | 43407 | B | V03AF01 | 1981-03-31 |
| Uromitexan | 53391 | B | V03AF01 | 1997-12-19 |
| Uromitexan Multidose | 53401 | B | V03AF01 | 1997-08-11 |
Frequently asked questions
How many medicines does Baxter AG have authorised in Switzerland?
Baxter AG is recorded by Swissmedic as the authorisation holder for 30 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Baxter AG based?
The Swiss location recorded for Baxter AG is Opfikon, Zurich.
Is Baxter AG a Swissmedic authorisation holder?
Yes. Baxter AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.